Foroogh Hosseini
Overview
Explore the profile of Foroogh Hosseini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alemi F, Poornajaf Y, Hosseini F, Vahedian V, Gharekhani M, Shoorei H, et al.
Mol Biol Rep
. 2024 Feb;
51(1):308.
PMID: 38366290
The DNA damage response (DDR) is a crucial cellular signaling pathway activated in response to DNA damage, including damage caused by chemotherapy. Chemoresistance, which refers to the resistance of cancer...
2.
Malakoti F, Alemi F, Jafari Yeganeh S, Hosseini F, Shabestani N, Samemaleki S, et al.
Chem Biol Drug Des
. 2022 Aug;
101(5):1151-1161.
PMID: 35993390
LncRNAs and miRNAs are the two most important non-coding RNAs, which have been identified to be associated with cancer progression or prevention. The dysregulation of lncRNAs conducts tumorigenesis and metastasis...
3.
Hosseini F, Shanehbandi D, Soleimanpour J, Yousefi B, Alemi F
Drug Res (Stuttg)
. 2022 May;
72(6):312-318.
PMID: 35636434
Chemotherapy, which is one of the common treatments for osteosarcoma (OS), has many side effects and in some cases has low effectiveness due to chemoresistance, hence it is vital to...
4.
Abolhasani S, Khabbazi A, Hosseini F, Gholizadeh-Ghaleh Aziz S, Alipour S
Int J Ophthalmol
. 2022 May;
15(5):813-819.
PMID: 35601158
Aim: To investigate effects of anti-TNF biologic drugs on uveitis severity (comparing visual acuity logMAR levels) in Behçet patients. Methods: Three databases PubMed, Scopus, and the Web of Science were...
5.
Hosseini F, Alemi F, Malakoti F, Mahmoodpoor A, Younesi S, Yousefi B, et al.
Biochem Pharmacol
. 2021 Sep;
193:114758.
PMID: 34481813
Osteosarcoma (OS) is an adolescent and young adult malignancy that mostly occurs in long bones. The treatment of OS is still a big challenge for clinicians due to increasing chemoresistance,...